about
PPARgamma and LXR signaling inhibit dendritic cell-mediated HIV-1 capture and trans-infectionRequirement for DNA CpG content in TLR9-dependent dendritic cell activation induced by DNA-containing immune complexesA lipidated anti-Tat antibody enters living cells and blocks HIV-1 viral replication.Nuclear receptor signaling inhibits HIV-1 replication in macrophages through multiple trans-repression mechanismsBlimp-1, an intrinsic factor that represses HIV-1 proviral transcription in memory CD4+ T cells.The stimulation of Toll-like receptors by nuclear antigens: a link between apoptosis and autoimmunity.Toll-like receptors, endogenous ligands, and systemic autoimmune disease.Porphyromonas gingivalis-mediated signaling through TLR4 mediates persistent HIV infection of primary macrophages.RNA-associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagement.Retinoid-dependent restriction of human immunodeficiency virus type 1 replication in monocytes/macrophagesComparison of CpG s-ODNs, chromatin immune complexes, and dsDNA fragment immune complexes in the TLR9-dependent activation of rheumatoid factor B cells.Immunologic environment influences macrophage response to Porphyromonas gingivalis.Retinoic acid inhibition of chromatin remodeling at the human immunodeficiency virus type 1 promoter. Uncoupling of histone acetylation and chromatin remodeling.Inhibitors of protein-disulfide isomerase prevent cleavage of disulfide bonds in receptor-bound glycoprotein 120 and prevent HIV-1 entry.Interleukin 1 beta and interleukin 6 potentiate retinoic acid-mediated repression of human immunodeficiency virus type 1 replication in macrophages.Alteration of hsp82 gene expression by the gypsy transposon and suppressor genes in Drosophila melanogaster.A new approach to investigating the relationship between productive infection and cytopathicity in vivoIL-16 anti-HIV-1 therapyActivation of autoreactive B cells by CpG dsDNADNA and RNA autoantigens as autoadjuvantsToll-Like Receptor-Dependent Immune Complex Activation of B Cells and Dendritic Cells
P50
Q33628817-76F8D3FE-0308-4B04-87F1-414A2FB4BD34Q33815085-3B05C80A-DFA6-423D-B81F-3EA8A7FB4B42Q34064505-5B2A94DE-86E6-4246-9508-DD087E06D3D3Q35274791-F8E117DE-0EC4-4C81-9A6E-9A543D015CA7Q35567041-FAE389E5-F2DA-49DF-A05D-88851DD4264DQ35839773-E4B093FC-3F5E-45B6-959B-1919748AC956Q36079856-AFBEED46-7DF6-4768-B213-6AF2D1204A64Q36136378-F85C5269-BA5A-4C6F-945E-EA8C7E85C698Q36403678-86F562AB-37FC-4E71-B878-94C38CADB653Q36509253-A5D4AF39-3051-4CC6-AA3B-35A737D9C14DQ38336526-B387CA6A-A4A4-4806-A785-168C48B321F5Q39653247-B886FC7B-C002-45E0-A1AE-AB4379BF3EB1Q40527620-7449157E-5589-441F-88D2-01E45FC6C871Q40705642-C00E867A-4BA1-4E8B-863D-518B86177A80Q45732036-40D15BF1-5926-4F7C-9FD9-35F7B5B4F9D9Q52453391-5192636C-FA34-48EE-80A0-9486C2B5139CQ73034311-C8645425-8524-4D47-A74B-25F296E3AA22Q73677549-D14A5A91-9B55-4BEA-A76E-BC8FA95A0834Q79361609-167EC21E-BB92-4195-856A-3B88B0F32C29Q79663762-5ADB8CC3-DE05-449C-BF9F-B96D18DE8158Q87146740-3FCF9169-DBF7-43F9-87FF-E2A0DC4CB4FA
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Gregory A Viglianti
@ast
Gregory A Viglianti
@en
Gregory A Viglianti
@es
Gregory A Viglianti
@nl
Gregory A Viglianti
@sl
type
label
Gregory A Viglianti
@ast
Gregory A Viglianti
@en
Gregory A Viglianti
@es
Gregory A Viglianti
@nl
Gregory A Viglianti
@sl
prefLabel
Gregory A Viglianti
@ast
Gregory A Viglianti
@en
Gregory A Viglianti
@es
Gregory A Viglianti
@nl
Gregory A Viglianti
@sl
P106
P21
P31
P496
0000-0002-0244-8293